{"sourcedb":"DevicePMAs@therightstef","sourceid":"P960001_S001","text":"Approval for new PMMA/MMA-Styrene co-polymer formulation.  The device, as modified, will be marketed under the trade Endurace Bone Cement and is indicated for the fixation of prostheses to living bone in orthopedic musculoskeletal srugical procedures for rheumatoid arthritis, osteoarthritis, traumatic arthritis, osteoporosis, avascular necrosis, collagen disease, severe joint destruction secondary to trauma or other condtions and revision of previous arthroplasty.","project":"consensus_PMA_Age_Indications"}